Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients

Different highly effective interferon-free treatment options for chronic hepatitis C virus (HCV) infection are currently available. Pre-existence of resistance associated variants (RAVs) to direct antiviral agents (DAAs) reduces sustained virologic response (SVR) rates by 3–53% in hepatitis C virus...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietz, Julia, Susser, Simone, Berkowski, Caterina, Perner, Dany, Zeuzem, Stefan, Sarrazin, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552686/
https://www.ncbi.nlm.nih.gov/pubmed/26317755
http://dx.doi.org/10.1371/journal.pone.0134395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552686/
https://www.ncbi.nlm.nih.gov/pubmed/26317755
http://dx.doi.org/10.1371/journal.pone.0134395

Ejemplares similares